These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Normal transcription of the beta-hexosaminidase alpha-chain gene in the Ashkenazi Tay-Sachs mutation. Paw BH; Neufeld EF J Biol Chem; 1988 Feb; 263(6):3012-5. PubMed ID: 2449434 [TBL] [Abstract][Full Text] [Related]
15. Tay-Sachs disease-causing mutations and neutral polymorphisms in the Hex A gene. Myerowitz R Hum Mutat; 1997; 9(3):195-208. PubMed ID: 9090523 [TBL] [Abstract][Full Text] [Related]
17. Novel Vector Design and Hexosaminidase Variant Enabling Self-Complementary Adeno-Associated Virus for the Treatment of Tay-Sachs Disease. Karumuthil-Melethil S; Nagabhushan Kalburgi S; Thompson P; Tropak M; Kaytor MD; Keimel JG; Mark BL; Mahuran D; Walia JS; Gray SJ Hum Gene Ther; 2016 Jul; 27(7):509-21. PubMed ID: 27197548 [TBL] [Abstract][Full Text] [Related]
18. Biochemistry and genetics of Tay-Sachs disease. Gravel RA; Triggs-Raine BL; Mahuran DJ Can J Neurol Sci; 1991 Aug; 18(3 Suppl):419-23. PubMed ID: 1834320 [TBL] [Abstract][Full Text] [Related]
19. Impact of gene patents and licensing practices on access to genetic testing and carrier screening for Tay-Sachs and Canavan disease. Colaianni A; Chandrasekharan S; Cook-Deegan R Genet Med; 2010 Apr; 12(4 Suppl):S5-S14. PubMed ID: 20393311 [TBL] [Abstract][Full Text] [Related]
20. Tay-Sachs disease in persons of French-Canadian heritage in northern New England. Palomaki GE; Williams J; Haddow JE; Natowicz MR Am J Med Genet; 1995 May; 56(4):409-12. PubMed ID: 7604851 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]